Navigation Links
Dr. Ken Kaitin, Tufts CSDD, Keynotes Preclinical Conference
Date:8/25/2011

BOSTON, Aug. 25, 2011 /PRNewswire/ -- CBI, a division of Advanstar Communications, is pleased to announce that Dr. Ken Kaitin, Director of the Tufts Center for the Study of Drug Development and Research Professor at Tufts University School of Medicine, is the keynote speaker at their Pharma/Bio Forum on Preclinical Development. The conference is being held September 26-27, 2011 at the Hyatt Harborside in Boston, MA. Dr. Kaitin will review today's research and development landscape and discuss how companies are restructuring to maximize efficiency and boost productivity.

Key success factors for many leading pharmaceutical companies include: alliances and partnerships, understanding the challenges of academic-industry relationships and leveraging translational science. Dr. Kaitin will share insight on the changing environment for preclinical development and new models of innovation. Learn more about Dr. Kaitin's keynote presentation here.

The recently announced Pfizer innovation center in Boston is just one example of how pharma plans to increase R&D efficiency and lower expenses by teaming up with local hospitals and academic research institutions for innovative drug discovery and translational R&D. Conference presentations designed specifically for those leading innovation in preclinical development include: Best methods for selecting and contracting with a CRO, understand oversight, management and quality challenges with global outsourcing, how to effectively partner with academic institutions, In-licensing and out-licensing - what both sides need to know.

For more information, please call 800-817-8601 or to view the entire agenda please visit http://www.cbinet.com/preclinical or review the agenda. To apply for a press pass, please contact Lauren Donoghue: lauren.donoghue@cbinet.com.

Event Sponsors include Toxikon and MPI Research.

About CBI

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 3 Tufts engineering faculty earn prestigious national awards for promising research
2. The Jackson Laboratory and Tufts University Announce New Ph.D. Track in Mammalian Genetics
3. Tufts Launches Institute for Biopharmaceutical Partnerships
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
6. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
7. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
8. Covance Decides to Pursue Its Original Preclinical Strategy in China
9. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
10. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
11. NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper ... information on the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent ... profiling of therapeutic antibodies. , To meet this demand, the team at ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... innovative Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered ... for high-pressure feed pumps in SU tangential flow filtration (TFF), virus filtration ...
Breaking Biology Technology:
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
Breaking Biology News(10 mins):